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Synergistic interactions among transcription factors (TFs) and their cofactors collectively determine gene
expression in complex biological systems. In this work, we develop a novel graphical model, called Active
Protein-Gene (APG) network model, to quantify regulatory signals of transcription in complex
biomolecular networks through integrating both TF upstream-regulation and downstream-regulation
high-throughput data. Firstly, we theoretically and computationally demonstrate the effectiveness of APG
by comparing with the traditional strategy based only on TF downstream-regulation information. We then
apply this model to study spontaneous type 2 diabetic Goto-Kakizaki (GK) and Wistar control rats. Our
biological experiments validate the theoretical results. In particular, SP1 is found to be a hidden TF with
changed regulatory activity, and the loss of SP1 activity contributes to the increased glucose production
during diabetes development. APG model provides theoretical basis to quantitatively elucidate
transcriptional regulation by modelling TF combinatorial interactions and exploiting multilevel
high-throughput information.
H
igh-throughput technologies, such as DNA microarray, deep sequencing, yeast 2-hybrid, and protein
mass spectrometry, generate tremendous amount of data at genome-wide scale and also at different
molecular levels1–5, which provides snap shots of the cells under different conditions. To explore rich
information of such high-dimensional data, computational methods are needed for identifying key genes, such as
transcriptional factors (TFs), and also for inferring their upstream-regulation and/or downstream-regulation
interactions. Differential expression analyses are widely used to find hot-spot genes or proteins. However, the
results derived simply based on only the abundance of mRNAs or proteins sometimes show low accuracy or even
lead to wrong conclusions6. For example, a TF which regulates its target genes by binding to DNA with its
cofactors may change its function or activity by interacting with different cofactors or rewiring its network even
without any alteration of its mRNA or protein expression level. Thus, although many of TFs play central roles
during a perturbed biological process, they exhibit no significant changes at mRNA or protein levels and thereby
are frequently overlooked by scientists. On the other hand, molecular interactions or regulatory relations such as
TF-TF interactions or TF-target gene regulations found by in vitro experiment in one condition do not always
exist in other conditions. As a result, an imperative and challenging task remains to quantify TF activities and
reveal their interactions so as to elucidate the key regulatory processes behind physiology and pathology7–9, by
making better use of the multilevel high-throughput data.
TFs are usually key regulators of cell fate or biological processes. In recent years, several research works have
studied TF functionality, i.e., TF activities, through mRNA expression profiling. Liao et al. developed a statistical
assumption-free approach, named Network Component Analysis (NCA), to infer TF activity, which reflects the
ability of TFs to regulate the transcription of mRNAs10. Meanwhile, Carro et al. inferred de novo TF-target
interactions by an information theoretical approach, namedARACNe, and then discovered themaster regulators
of mesenchymal transformation by computing the statistical significance of the overlap between the targets of
each TF and the MGES genes by Fisher’s exact test11. Both NCA and ARACNe identify TF activities by using
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providing a computational way to discover key regulators even with-
out abundance changes of their mRNA levels, dramatically improve
our understanding of underlying functions for those ‘‘hidden’’ or
‘‘unobservable’’ key TFs. Nevertheless, since many TFs, regulating
their target genes, change their functional roles by interacting with
different cofactors, TF activities are mainly determined by protein
interactions among TFs and their cofactors, i.e., TF upstream-regu-
lation information, rather than the downstream-regulation informa-
tion. Therefore, to infer TF activity in an accurate manner, it is
important to exploit TF upstream-regulation information (e.g.,
expression levels of TF cofactors) in addition to TF downstream-
regulation information (e.g., expression levels of TF target genes).
Enlightened by this fact, we extend the concept of TF activity
described by Liao et al.10 as an integrative index reflecting not only
cooperativity of transcriptional factors with cofactors but also the
ability of transcriptional complexes to regulate the transcription of
mRNAs. That is, we propose a novel method based on a causal
‘‘cofactor-TF-target’’ cascade, called Active Protein-Gene (APG)
network model, by integrating both upstream-regulation and down-
stream-regulation structures of TFs to quantitatively infer not only
regulatory strengths of TFs but also their regulatory network struc-
ture. Unlike the previous approaches mainly using the mRNA
information of TF targets (i.e., TF downstream-regulation informa-
tion), APG integrates both TF upstream-regulation and down-
stream-regulation information, thereby requiring less samples and
TF-target connectivity information to ensure the accurate inference
of TF activities and network structure. Specifically, we first theoret-
ically prove that there is a unique solution for APG model even
without prior knowledge based on a graphical model and matrix
factorization theory, which significantly extends previous methods
based only on downstream-regulation information. We also numer-
ically show that APG always has higher accuracy than the down-
stream-regulation information methods, for the cases not only with
less prior knowledge but also with higher white noise. Second, we
examine the performance of APG model by applying it to liver
microarray data from type 2 diabetic GK rats and Wistar controls12.
GK colony is established bymore than 30-generation repeated breed-
ing of Wistar rats with blood glucose in upper limit of normal dis-
tribution for glucose tolerance13. Spontaneous hyperglycemia in GK
colony is not established by single gene mutation, thus GK rat is
considered as one of the best animal models for studying type 2
diabetes, which represents majority of all cases in diabetes13. Being
a valuable tool offering sufficient commonalities to study human
Type 2 diabetes, finding key hidden TFs with changed activities
and also their regulatory network in diabetic GK rats will provide
pathological hypotheses for human disease. Actually, by applying
APG to animal models, we identify several hidden TFs, especially
SP1, during development of diabetes, which cannot be detected by
the traditional differential expression scheme due to no significant
differential expression for SP1. Third, APG discovers the rewiring
network of TFs and their regulatory targets by comparing GK rats
and Wistar controls. In particular, for the first time, strong correla-
tions of E2F1 and BAHD1 to GCK in Wistar rats are revealed, in
contrast to weak correlations of SP1, E2F1 and BAHD1 to GCK in
GK rats. Finally, we conduct the biological validation experiments, in
which we confirm not only the relevant network structures of the TFs
but also SP1 as a key TF with the hidden regulator activity. In par-
ticular, we show that the loss of SP1 activity contributes to the
increased glucose production during diabetes development in GK
rats.
Results
Active Protein-Gene (APG) network model. In contrast to models
mainly using known or de novo predicted TF downstream-regulation
information, theAPGmodel integrates both TF upstream-regulation
and downstream-regulation information by exploiting causal
cofactor-TF-target relations, i.e. protein interactions among TF
and cofactors, concentrations of TF and cofactors, TF-target connec-
tivity, expression levels of target genes, and other factors (Figure 1).
For this purpose, our model is composed of three layers. The first
layer consists of proteins including transcriptional factors, cofactors,
or other proteins related to the activity of TFs such as kinase and
phosphatase, which is the layer of the cause of TF activity. The second
layer represents the TF activity, which shows cooperativity of tran-
scriptional factors with cofactors or the ability of TFs to activate (or
repress) target gene transcription. This is a hidden layer acting as a
modulator to transform signals of TFs and their cofactors to their
target genes, i.e. values in this layer cannot be directly experimentally
measured. The third layer including expression levels of different
target genes is the effect or result of TF activity.
We represent concentrations of proteins affecting TF, TF activ-
ities, and expression level of targets with random variables
Q~ Q1,    ,QL,    ,QKð Þ, P~ P1,    ,PLð Þ, and E~ E1,    ,ENð Þ,
respectively. Here, Q1,    ,QL are concentrations of TF, and
QLz1,    ,QK are concentrations of proteins modifying TF.
According to the dependent and conditional independent feature
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where pa Xð Þ stand for all parents of node X in Bayesian network.
Clearly, pa Plð Þ or pa Enð Þ are a subset of Q or P.
In this model, random variables can be both discrete and continu-
ous. Here we consider continuous case. A natural choice for repre-
senting continuous variables is the use of Gaussian distribution.
According to the linear Gaussian model, we have the conditional
density of X given its parents






where A1,    ,Ak are the parents of X; N m,s2
 
is the density func-
tion of the normal distributionwithmeanm and standard variation s,
and a1,    ,ak are the observations ofA1,    ,Ak respectively. li is the
effect strength of the ith variable. Here, the variation s is independent
of the value of parents. Since the activities of TFs depend on con-
centrations of both TFs and corresponding cofactor proteins, we
have








where l~1,2,    ,L; qk is the observed value of Qk; blk is the effect
strength of the kth protein on the lth TF. Similarly, we have








where n~1,2,    ,N ; pl is the potential observed value of Pl ; anl is the
regulatory strength of the lth TF on the nth target gene.




























where a, b are parameters on network structure; m, s are parameters
on data, and p, q are respectively absent and observed data.
To infer the optimal parameters or network structure of the
graphical model, we use Maximum Likelihood Estimation (MLE)
to maximize the probability of observed data14. Particularly, if
www.nature.com/scientificreports
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there are M independent observations of Q and E, we let
H~ a,b,mQk ,sQk ,sEjpa,sPjpa
 
, then the MLE is to maximize log-
arithm likelihood function L HjQ,Eð Þ~ logP
M
i~1
Pr Qi,P,Eið Þ½ , where
Qi,Ei are respectively observed values of Q,E in ith sample. To do
that, the hard-assignment version EM strategy14 is carried out as
shown in Supplementary Text S1. Thus, we can obtain the network
structure (a,b) and TF activities (P) provided that we get H.
Conditions of unique solution for TF activities and network
structure. One important question to apply AGP model is whether
or not the solution for TF activities and network structure is unique.




where (5) considering TF-downstream-regulation information of P
is actually the framework of NCA. Specifically, E being measurable is
a N|M matrix representing expression level of N genes under M
different conditions.A is TF downstream-regulation structure which
is the N|L connectivity matrix representing the regulations
between L TFs and N targets. P being immeasurable is an L|M
matrix representing TF activity at these M conditions. On the
other hand, (6) considers TF-upstream-regulation information of
P. Specifically, B is TF upstream-regulation structure which re-
presents the effect of protein on TF activity including modifica-
tions of proteins and TF concentrations; Q are the concentrations
of TF and activities of modifying proteins. Clearly, by substituting (6)
into (5), we have E~ABQ. If E or Q as well as partial elements of A
and B are given, the variables to be determined are the remaining
unknown elements of A and B.
Then, if we assume that ith TF does not directly affect the activity of
jth TF for i=j, we can prove that the solution of (5–6) is unique up to
a scaling factor when A has a full-column rank and Q has a full-row
rank (refer to Corollary 2 in Supplementary Text S2). That is to say by
integrating both TF upstream-regulation and downstream-regulation
structures, APG ensures the unique solution for TF activities and their
network structure even with no requirement on prior knowledge of
TF-target information or kinase-TF information, which extends the
results of NCA in (reference 10).
More generally, if the assumption that ith TF directly affects the
activity of jth TF for some i=j is not invalid, we derive another series
of conditions to ensure the unique solution for APG, which also
require less TF-target information than the traditional (down-
stream-regulation) methods (Supplementary Text S2 Theorem 1
and Corollary 1).
Numerical experiments. To illustrate the effectiveness of our
method, we firstly constructed two simple networks. The first one
contains one protein, one TF and two targets with prior knowledge
satisfyingNCA criterions (Supplementary Figure S1), and the second
one contains two TFs, three candidate cofactors, and three candidate
targets with prior knowledge not satisfying NCA criterion ii
(Supplementary Figure S3). However, both of the two examples
satisfy the conditions of APG. We applied APG to infer TF activity
and network structures from 10 samples randomly generated by
normal distribution. All TF activities and network parameters were
successfully deduced by APG even without any prior information
(Supplementary Figures S2 and S4). To quantitatively compare the
efficiency of APG and the downstream-regulation method on these
two examples, we defined the Root Mean Square Deviation (RMSD)














wherem is the number of samples, yTFAj is the real activity of TFj and
y^TFAj is the inferred activity. Then we calculate RMSD for APG and
the downstream-regulation method at different noise level (s).
Supplementary Figure S5 A and B show the results of APG and the
downstream-regulation method on the first and second net-
works, respectively. Both the downstream-regulation method and
APG work well on the first network when s is small (RMSD is
small). With the increase of noise, accuracy (mean value of RMSD)
Figure 1 | Schematic diagram of APG model. There are causal relations between protein interaction and transcriptional regulation. APG model
integrates both TF upstream-regulation and downstream-regulation information by exploiting causal ‘‘cofactor-TF-target’’ relations, i.e., protein
interactions among TF and cofactors, concentrations of TF and cofactors, TF-target connectivity, expression levels of target genes, and other factors.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 1097 | DOI: 10.1038/srep01097 3
and convergent stability (standard deviation) of both methods
gradually deteriorate, but APG with smaller standard deviation
and RMSD always outperformed the downstream-regulation
method. In the second network, the downstream-regulation
method resulted in big errors while APG still gave the solution
with reasonable accuracy and convergence. Then we compared
convergent rate for the downstream-regulation method and APG
within given number of iteration steps. As shown in Supplemen-
tary Figure S5 C and D, clearly APG is superior to the downstream-
regulation method, showing that APG has a better convergent rate.
Besides, we compared RMSD and convergent rate of APG and the
downstream-regulation method for different sample sizes. Numerical
experiments on these two networks also show superiority of APG
comparing with the downstream-regulation method (Supplementary
Figure S6).
To further illustrate the effectiveness, we constructed amore com-
plex artificial example with 50 TFs, 50 cofactors and 200 target genes,
following the workflow shown in Supplementary Figure S7. Firstly,
we simulated protein concentrations of TFs and cofactors by random
numeric values following normal distribution with fixedmean values
and standard deviations for each protein. Secondly, the TF activities
were deduced by protein concentrations and active TF-cofactor
cooperation network. Specifically, to construct the active TF-cofactor
cooperation network, we firstly assumed that there is a potential TF-
cofactor protein interaction network for the organism we are inter-
ested in, and then removed h% of all edges by random to generate TF
activity following formula (2) with standard deviation s. Here, the
potential TF-cofactor interaction network was randomly con-
structed with cofactor out-degree following power-law distribution.
Thirdly, we constructed the potential TF-target regulatory network,
randomly produced the active TF-target network, and generated the
simulated gene expression data by formula (3) with similar strategy.
In this example, we tried to infer TF activity additional with active
network structure, under the assumption that protein concentra-
tions, gene expression level, potential TF-cofactor interaction net-
work, and potential TF-target regulatory network are available data.
To do that, we applied APG from 100 samples randomly generated
by strategy described above. TF activities and network parameters
were successfully deduced by APG in most cases. To compare the
efficiency of APG and the downstream-regulation methods (i.e.,
downstream-regulation information based methods) on this
example, we calculated RMSD for APG and the downstream-regu-
lation methods at different inactive rate (h) and different noise level
(s). Figure 2A and 2B show the results of APG and the downstream-
regulation methods, respectively. Both the downstream-regulation
methods and APG work well on the first network when s and h are
small. With the increase of noise or inactive rate, accuracy of both
methods gradually deteriorated, but APG always outperformed the
downstream-regulation methods due to the integration of more
information (Figure 2A and 2B).
APGmodel infers TF activity in diabetic GK ratmodel.As a proof-
of-concept application, we used APG model on the diabetic GK rat
data collected above. Specifically, there are total 50 samples across
five time points, with five diabetic rats and five normal rats at each
time point as shown in Supplementary Figure S8. For each gene or
protein (here gene expression level was used to approach protein
concentration), we used xit to represent its expression level in the
liver of GK rat i at time point t, and yjt Wistar rat j at time point t. In
order to figure out which TF is the master or key regulator in
regulating differentially expressed genes in diabetic rat, we pre-






. Then we got the differentially expressed levels of
all TFs, cofactors, and targets genes of 25 samples across all five time
points (five for each). Then we ran APG with input of 113 TFs, 121
cofactors, 335 targets in 25 samples, and obtained the TF activities of
all TFs at each sample. Noticing that there are five samples at each
time point, we further calculated p-value to evaluate whether TF
activity is larger than zero (gain of activity in diabetic rat com-
paring with normal) or less than zero (loss of activity in diabetic
rat comparing with normal) at each time point for each TF with T-
test. Finally, we showed that fold changes of activities of 25 TFs are
significantly different from the corresponding fold changes of the
mRNA levels between GK and Wistar rats at more than one time
points in Figure 3A. Interestingly, most of the TFs showing above
with high or low activities have moderate or even opposite mRNA
changes compared GK with Wistar. This indicates that, in terms of
TFs, the mRNA and activity separation is not a rare case.
In particular, we found the remarkable differences between the
activities and their mRNA expression levels of 3TFs, i.e., JUN, SP1
and STAT5B. The three TFs showed no significant fold changes of
the mRNA expression levels but had highly significant differences in
their activity levels at least 4 time points. SP1 is a housekeeping gene
binding with high affinity to GC-rich motifs and regulating a variety
of functions such as cell growth and apoptosis17,18. JUN is highly
similar to the viral protein avian sarcoma virus 17, which is well
known to be involved in both translocations and deletions in human
malignancies19. A weaker DNA binding of STAT5B has been linked
to defective pathways contributing to diabetes in mice20,21. It is well
Figure 2 | Numerical experiments showing the ability of APG for inferring TF activity and reconstructing network structure. (A) RMSD is computed
to measure the accuracy between predicted activity and actual activity. With different inactive ratio h, APG always obtain better accuracy.
(B) RMSD of APG and the downstream-regulation based methods with different noise levels.
www.nature.com/scientificreports
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known that diabetes is reversible during early stage, but the informa-
tion during early development of diabetes is rare. Thus we picked 4
weeks of age to study hidden TFs whichmight contribute to develop-
ment of diabetes. We first selected SP1 as the candidates of hidden
regulators to further experimental verification. Since both JUN and
STAT5B did not show significant TF activity changes at 4 week, we
selected JUN as a TF without significant change of activity. In addi-
tion, RXRG, which only has significant differences of the activity at
only 12 weeks of age, was also selected as a control. RXRG interacts
with the retinoic acid, thyroid hormone, and vitamin D receptors
increasing their functions22. As a result, we selected the three tran-
scription factors, JUN, SP1 and RXRG, to validate them as hidden
regulators and controls in 4 week diabetic GK rats.
We first checked the mRNA expression levels of the three TFs in
the livers from 4 weeks old GK and Wistar rats. The real-time PCR
results showed that mRNA levels of all three genes were not signifi-
cantly different between GK and Wistar rats at 4 weeks, comparable
to those in the microarray data (Figure 3B). In order to confirm
activity levels, direct and indirect methods were used. Some TF activ-
ities are correlated to domain phosphorylation, thus their activities
can be directly measured by their protein phosphorylation levels.
JUN, also called c-Jun, is activated through double phosphorylation
by the c-Jun N-terminal kinases (JNKs) on Ser-63 and Ser-73 within
its transcriptional activation domain. Thus wemeasured JUN-Ser-63
protein levels in the liver of GK andWistar rats at 4 weeks of age. As
seen in Figure 4A, the phosphorylation levels of JUN-Ser-63 showed
no significant difference between Wistar and GK rats, which indi-
cated no alteration of the transcriptional activity of JUN, in consist-
ence with APG prediction.
Since activities of many TFs cannot be tested directly, we designed
an indirect way to speculate their activities. One of the most import-
ant characteristics of type 2 diabetes is the phenomenon of the
increased glucose production in liver. The activity of SP1, but not
RXRG, is significantly different as predicted by APG.We believe that
if the predictions are true, we should certainly observe the different
changes of glucose production in primary hepatocytes from Wistar
and GK rats after knocking down TF by specific small interference
RNA (siRNA). To test this hypothesis, we transfected siRNAs, which
are specific to SP1 and RXRG, into primary hepatocytes of Wistar
andGK rats, and analyzed theirmRNA expression levels by real-time
PCR. When SP1 mRNA levels were dramatically decreased by
siRNA, glucose productions from Wistar rat hepatocytes were mea-
sured. While knocking-down SP1 mRNA levels caused a significant
14% up regulation of glucose production from Wistar rat hepato-
cytes, no significant changes were observed in GK hepatocytes after
similar SP1 mRNA knocking down (Figure 4B and 4C). In contrast,
about 90% RXRG mRNA knocking down in GK and Wistar hepa-
tocytes did not significantly change glucose production in both GK
Figure 3 | Results of APG on biological data. (A) TFs with significant activity changes. We first collected the liver gene expression data from GK and
Wistar rats in Gene ExpressionOmnibus (GEO) database (GSE 13271). For each time point, mean and standard variant were calculated on five biological
repeated samples for both activity and mRNA levels of corresponding TF. W means weeks of age. (B) Relative mRNA levels of RXRG, SP1,
and JUNweremeasured in the livers from 4-week oldWistar (n55) andGK (n56) rats. There were no significant changes of these three gene expressions
between GK and Wistar rats.
www.nature.com/scientificreports
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andWistar hepatocytes at 4 weeks of age, which suggests that RXRG
activity is not closely related to liver glucose metabolism changes
during this age. These results suggest that, in terms of glucose pro-
duction, SP1 is functional in 4-week Wistar rats. Despite similar
mRNA levels, the activities of SP1 are lost in diabetic GK rats at 4
weeks of age. In such ways, the activities of SP1 as a hidden regulator
contributing to development of diabetes were verified by glucose
production.
Network rewiring inferred by APG in development of diabetes.
Identifying network rewiring in diabetes at early stage can provide
valuable information on the biological mechanisms of the initiation
and development for the disease. Blood glucose levels of GK rats at 4
weeks of age do not reach the established glucose criteria for the
diagnosis of diabetes, thus animals at this age are considered
prediabetes23. To infer network rewiring in 4-week old prediabetic
GK rats, we firstly selected all significant TFs at 4 weeks of age, and
then used them as seeds to reconstruct upstream-regulation and
downstream-regulation cascades by network structure predicted by
APG. Specifically, for given TF l, if not only anlj jw0:1 but also gene n
is significantly differentially expressed between diabetic and normal
rats (p-value,0.05), gene n is selected as one of the down
stream-regulation targets. Similarly, if blkj jw0:1 and cofactor k is
significantly differentially expressed between GK and Wistar,
cofactor k is selected as one of the upstream-regulation cofactors at
4-week old. As shown in Figure 5A, diamonds and squares represent
TF activities (diamonds represent high activity while squares low
activity). EGR1 and RXRA have higher activities, while TFs,
such as SP1, PPARA, RXRB, ARNT, STAT1, NPAS2, RELA, and
NEUROG3, have lower activities. We also constructed the causal
and regulated layers of the genes presenting in circles, based on the
connectivity matrix and gene expression profile as described above.
TF upstream-regulations are presented by dash lines, while the solid
lines indicate TF downstream-regulation signals. The mRNA levels
of all genes are showed by spectrum colors from green to red (green
mean lower expression level in diabetic rats, while redmeans higher).
We firstly check the enriched GO terms byNOA (Network Ontology
Analysis), which is a novel Gene Ontology tool aiming to analyze
Figure 4 | Validation of activities. (A) No significant changes of JUN-Ser-63 in the liver tissues from Wistar (n55) and GK rats (n56). The
phosphorylation levels of JUN were determined by Western Blot, and then analysed by densitometry. (B) Gene expression after siRNA knocking down.
Primary hepatocytes isolated fromWistar and GK rats were transfected by negative control siRNA (NC), Rxrg and SP1 specific siRNA. The mRNA levels
of SP1 and Rxrg were significantly decreased after specific siRNA transfection. The gene knocking down degrees in Wistar and GK primary hepatocytes
were comparable. (C) Glucose production of primary hepatocytes isolated from Wistar or GK rats after siRNA knocking down. Knocking down SP1
mRNA levels caused a significant up regulation of glucose production from Wistar rat hepatocytes. No significant changes in glucose production were
observed in GK rat hepatocytes after similar SP1 mRNA knocking down. Knocking down RXRG mRNA levels did not significantly change glucose
production in hepatocytes from both GK and Wistar rats at 4 weeks of age. For Figure B and C, Error bar indicates standard deviation for each group
(n53) in three separate experiments.
www.nature.com/scientificreports
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functions of gene network instead of gene list34, and find that the
predicted interactions are significantly enriched in immune system
process, cellular response to chemical stimulus, and response to
vitamin A and hormone stimulus, during all biological processes
(Supplementary Table S1).
The APG network constructed above shows significantly differ-
ential TFs, cofactors, and target genes between GK and normal
controls, within which SP1 is an obvious hub. A large number of
growth and insulin responsive genes contain binding sites for the
transcription factor SP124. For instance, glucokinase (GCK), insulin-
like growth factor binding protein 2 (IGFBP2), and PPAR-c coacti-
vator (PGC) are well known proteins and their dysfunctions are
related to diabetes. From our previous published results and data,
we also reported that SP1 regulates nuclear factors working in con-
cert to keep normal glucose metabolism robustness25. The low activ-
ity of SP1 in GK rats may be associated with SP1 cofactors, that is,
lower expression of E2F transcription factor 1 (E2F1) and higher
expression of Bromo adjacent homology domain-containing pro-
tein 1 (BAHD1). SP1 and E2F1 act synergistically in activation of
downstream gene transcription in transient transfection assays
using Drosophila melanogaster SL2 cells26. BAHD1 is a novel
heterochromatinization factor that leads to histone deacetylation
and nucleosome compaction and reduces the ability of SP1 to pro-
mote transcription activities27. We observed that loss of SP1 activity
caused significant increment of glucose production (Figure 4C).
How SP1, as well as its potential cofactors E2F1 and BAHD1, affects
glucose production was further investigated. We picked GCK, which
is one target of SP1, discovered about 40 years ago independently in
three laboratories19,28,29. Tissue survey indicates that the enzyme is
liver specific, changing free glucose to glucose-6-phospharate for the
synthesis of glycogen, thus serving a critical role in postprandial
glucose clearance from the circulation30,31. In Supplementary
Figure S9, GCK expression levels significantly decreased in diabetic
GK rats, and GCK promoter clearly has SP1 binding region. As TF
and target gene pairs, SP1 and GCK in expression levels (Figure 5B)
were not significantly correlated in both normal Wistar and diabetic
GK rats (p-values are 0.32 and 0.42 respectively based on a Student’s
t distribution for a transformation of the correlation). Instead, for the
Figure 5 | (A) Network rewiring inferred by APG. Diamonds represent significantly active TFs, and squares represent significantly repressed TFs
comparingGK toWistar rats. The color of nodes ranging from green to red, representsmRNA expression levels from low to high compare GKwithWistar
controls. All dash lines represent physical interaction between genes and TFs, that is the TF upstream-regulation, and all solid lines represent regulation
between TFs and targets. (B) Robust fit showing the correlation between GCK expression and SP1, E2F1, BAHD1 in different rat models. (C) Knocking
down SP1 decreased GCK mRNA expression in Wistar rats, but not in GK rats. The primary hepatocytes from Wistar and GK rats were transfected by
negative control (NC) or SP1 siRNA for 24 hours. The GCK genemRNA level was measured 24 hours after transfection. mRNA expression levels of GCK
showed a remarkable decrease inWistar hepatocytes after SP1 knocking down, while there was no significant change in GK hepatocytes after similar SP1
mRNA knocking down. Error bar indicates standard deviation for each group (n53) in three separate experiments.
www.nature.com/scientificreports
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first time, we found out that E2F1 and BAHD1, the potential cofac-
tors of SP1, show strong correlations in expression levels with GCK
in Wistar controls (p-values are 0.00003 for E2F1 and 0.0001 for
BAHD1). Interestingly, all these correlations were dramatically wea-
kened in GK rats compared with those in Wistar controls (p-values
are 0.004 for E2F1 and 0.19 for BAHD1).
Those decreased correlations in GK rats are caused by low activity
of SP1. We used RNA interference method to test regulation of GCK
by SP1 in hepatocytes of GK andWistar rats. If the activity of the TF
is low in GK rat but high in Wistar rat, then the expression of the
target genes should be little changed in the primary hepatocytes of
GK rat but significant change in the primary hepatocytes of Wistar
rat after knocking down by the specific siRNA to the TF.We detected
themRNA expression level of GCK in primary hepatocytes ofWistar
rat and GK rat with or without SP1 knocking down by siRNA. As we
expected, the real-time results showed that there is rarely change in
GCKmRNA levels in hepatocytes of GK rat after SP1 siRNA knock-
ing down. In contrast, GCK expression of mRNA level was signifi-
cantly reduced in hepatocytes of Wistar rat after SP1 knocking down
(Figure 5C).
Discussion
We developed a new mathematical method, named APG model, to
quantitatively infer TF activities and network structures in an accur-
ate manner from high throughput biological data. Specifically, in
combination with gene expression levels, protein-protein interaction
network, and transcription regulatory network, we integrated both
TF upstream-regulation and downstream-regulation information to
reveal transcriptional regulations of TFs at the network level. We
theoretically prove that APG model has a unique solution for TF
activity and is able to find unknown elements (i.e., unknown regu-
lators and interactions) in the network structure even without
enough prior knowledge, which significantly extends the previous
methods in both theoretical and computational aspects. In addition,
APG directly considers combinatorial interactions among TFs and
cofactors, thereby enabling us to apply it to a wide class of biological
data or solve real biological problems without treating each TF and
cofactor in isolation. APG method with Gaussian graphical model,
consists of three layers representing cofactors (cause layer), TF activ-
ity (hidden layer), and regulated target genes (effect layer) respect-
ively, which can not only identify key factors in a biological process
but also reveal hidden potential causal relations among biomolecules.
The new approach was firstly validated by numerical experiments
and then by biological experiments. Comparing with approaches
only using downstream-regulation information, APG integrating
multi-level information infers both TF activities and their network
structure in amore accurate and robust manner. Moreover, applying
our method in diabetic rats actually found hidden TFs with the
changed activities during development of diseases, which cannot
be identified by the traditional differential gene scheme due to no
differential expression of those genes in microarray data. Actually,
for many cases, those genes with high differential expression may be
far from key regulators (or have even less relevance with the driving
factors of the biological phenomenon) due to a cascade amplification
effect of gene regulations from the key regulators, comparing to the
genes with low differential expression. We further investigated the
rewiring network of TFs and their regulatory targets in 4 week GK
rats in comparison with Wistar controls, and for the first time
revealed strong correlation of E2F1 and BAHD1 to GCK in Wistar
rats. Our biological experiments validated SP1 as a hidden TF with
changed regulatory activity, and the loss of SP1 activity was found to
contribute to the increased glucose production during diabetes
development in GK rats. Clearly, APGmodel provided opportunities
to enhance our ability to use microarray data to elucidate transcrip-
tional regulation in complex biological systems with combinatorial
interactions of TFs and their cofactors.
Biological systems like individuals, cells, evenmononuclear organ-
isms are complex robust systems, in which TF combinations
determine a specific phenomenon. Dr. Timothy screened for phys-
ical interactions of a large number of TFs and revealed highly inter-
acted TFs conserved between mouse and human32. However, those
methods only considering the significant changed mRNA or protein
levels frequently miss important molecules which change their roles
in the physiological or pathological process by rewiring TF interac-
tions with their cofactors. On the other hand, theoretical models only
considering TF downstream-regulation information may also miss
main features of TF combinatorial interactions in biological systems.
In contrast, APGmodel fully exploits TF upstream-regulation mole-
cules, TFs, and TF downstream-regulation molecules, thereby pro-
viding us a powerful tool to quantify TF activities and infer the
rewiring network of ‘‘cofactors-TFs-regulatory targets’’ behind a
phenotype in an accurate manner by integrating high throughput
data. Mapping the cofactors-TFs-regulatory targets interactions
would significantly enhance our understanding of developmental
processes and diseases. Applying APG to rodent high throughput
data, followed by experimental confirmation, revealed important
hidden roles of loss SP1 activity in development of diabetes in GK
rats. Our data is consistent with clinical investigation, in which a
dramatic reduction in Sp1 binding toGCKpromoter sequence corre-
sponds to GCK-MODY (maturity-onset diabetes of the young)
cases33. Since the decreased GCK function causes mild fasting hyper-
glycemia, identifying mutations causing GCK hypofunction has
important implications for treatment and prognosis; therefore, we
propose to analyse E2F1 and BAHD1 in addition to SP1 for correct
diagnosis of potential GCK-MODY. From our inferred network, SP1
also regulates important genes associated with metabolism, such as
PGC and IGFBP2, et al. Currently, little is known about the direct
role of SP1 in glucose metabolism of diabetes, partially due to similar
mRNA levels of SP1 during diabetes progression. The vital function
of SP1 in development and progression of diabetes has not gotten
enough attention, and thus needs further investigation in the future.
Molecular experiments like chromatin immunoprecipitation
(ChIP) and luciferase reporter assays provide us basic information
about TF and target gene pairs. However, these in vitro experiments
always treat each TF in isolation with unphysiological expression
levels. Thus in a real physiological and pathological conditions, those
regulation signals do not always exist. For example, the regulation of
GCK by SP1 is lost in diabetic animals, as well as the strong correla-
tions of BAHD1 to GCK. APG provides us a useful algorithm to
calculate a specific regulatory signal in a complex system without
treating each TF and cofactor in isolation. It has long been appre-
ciated that combinatorial interactions among TFs and their cofactors
change regulatory signals. Thus another significant contribution of
the present work is to precisely calculate the regulatory signals on a
global scale.
We found the relevance of loss of SP1 activity to diabetes in this
study. E2F1 and BAHD1 dysfunctions are potential reasons reducing
SP1 activity. However, it is also known that SP1 activities are involved
in the complicated post-translational modifications, such as phos-
phorylations, proteolytic cleavage, glycosylation, and acetylation24.
Thus we considered the mechanisms underlying loss of SP1 activity
as our future topic. In addition, it is also our future work to study TF
activities for biological or medical problems by considering dynam-
ical features35,36 of disease progression.
Methods
We first collected the gene expression data of TFs, potential cofactors and their target
genes from GK and Wistar rats in Gene Expression Omnibus (GEO) database (GSE
13271). There were totally 50 samples with different phenotype (diabetes and normal
control) in five different time points. We further selected targeted genes in the data
set, by setting the threshold of the fold change of gene expressions between GK and
Wistar rats (fold change .1.5 or ,1/1.5). Then, the prior knowledge including
protein-protein interaction networks, and TF-gene regulatory networks to construct
connectivity pattern (potential interaction network) was prepared from KEGG15,
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TRED database16 and homologous from human and mouse. Then we obtained 905
potential regulations between TFs and their targets, and among them, 468 pairs are
further known about their regulatory directions (activation or repression of target
expression). We also obtained 326 potential protein-TF interactions, and among
them, 263 pairs are known about regulatory directions (activation or repression of TF
activity). Finally, 113 TFs, 121 TF-interacting proteins, and 335 targets with both
network and expression information were selected for further research.
For the purpose to experimentally validate our results, maleWistar andGK rats at 4
weeks of age were purchased from SLRC Laboratory center. Animals were housed in
cages at a constant temperature with 12 hours light/dark cycles. Animals were given
free access to water and food. All experiments were approved by Institutional Animal
Care andUse Committee at shanghai Institutes of Biological Science, China Academy
of Sciences. Livers from fedWistar or GK rats were washed, and further digested with
0.04% collagenase (Worthington, LS004196). Cells with viability higher than 85% as
assessed by the trypan blue exclusion test were used for experiments. The primary
hepatocytes were cultured in DMEM medium with low glucose (1 g/L) (Invitrogen)
supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 ug/ml
streptomycin. We performed siRNA knockdown by transient transfection. Duplex
siRNA oligonucleotides were synthesized by GenePharma. Ltd (Shanghai, China).
The RFect transfection reagent was purchased from Bio-Tran Biotechnologies
(Shanghai, China). At 24 hours after transfection of siRNA, the hepatocytes were
gently washed with PBS three times, followed by incubation with glucose production
buffer (DMEM with no glucose but supplemented with 20 mM sodium lactate and
2 mM sodium pyruvate). Supernatant was collected for measuring glucose concen-
tration by fluorometric assay (Invitrogen). The results were further normalized with
total protein in whole-cell lysates. For detailed experimental methods, refer to the
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